{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:22:46Z","timestamp":1772670166728,"version":"3.50.1"},"reference-count":227,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007652","name":"Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria","doi-asserted-by":"publisher","award":["E-RTA2017-00003-C02-01"],"award-info":[{"award-number":["E-RTA2017-00003-C02-01"]}],"id":[{"id":"10.13039\/100007652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Zika virus (ZIKV) is a mosquito-borne flavivirus that spread throughout the American continent in 2015 causing considerable worldwide social and health alarm due to its association with ocular lesions and microcephaly in newborns, and Guillain\u2013Barr\u00e9 syndrome (GBS) cases in adults. Nowadays, no licensed vaccines or antivirals are available against ZIKV, and thus, in this very short time, the scientific community has conducted enormous efforts to develop vaccines and antivirals. So that, different platforms (purified inactivated and live attenuated viruses, DNA and RNA nucleic acid based candidates, virus-like particles, subunit elements, and recombinant viruses) have been evaluated as vaccine candidates. Overall, these vaccines have shown the induction of vigorous humoral and cellular responses, the decrease of viremia and viral RNA levels in natural target organs, the prevention of vertical and sexual transmission, as well as that of ZIKV-associated malformations, and the protection of experimental animal models. Some of these vaccine candidates have already been assayed in clinical trials. Likewise, the search for antivirals have also been the focus of recent investigations, with dozens of compounds tested in cell culture and a few in animal models. Both direct acting antivirals (DAAs), directed to viral structural proteins and enzymes, and host acting antivirals (HAAs), directed to cellular factors affecting all steps of the viral life cycle (binding, entry, fusion, transcription, translation, replication, maturation, and egress), have been evaluated. It is expected that this huge collaborative effort will produce affordable and effective therapeutic and prophylactic tools to combat ZIKV and other related still unknown or nowadays neglected flaviviruses. Here, a comprehensive overview of the advances made in the development of therapeutic measures against ZIKV and the questions that still have to be faced are summarized.<\/jats:p>","DOI":"10.3390\/ph12030127","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T10:31:17Z","timestamp":1567161077000},"page":"127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-5544","authenticated-orcid":false,"given":"Juan-Carlos","family":"Saiz","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria (INIA), 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5501\/wjv.v1.i2.51","article-title":"West nile virus: A re-emerging pathogen revisited","volume":"1","author":"Saiz","year":"2012","journal-title":"World J. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: Evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12992-016-0194-4","article-title":"Understanding ebola: The 2014 epidemic","volume":"12","author":"Kaner","year":"2016","journal-title":"Global Health"},{"key":"ref_4","first-page":"496","article-title":"Zika virus: The latest newcomer","volume":"7","author":"Saiz","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_5","unstructured":"WHO (2019, June 20). The History of Zika Virus. Available online: http:\/\/www.who.int\/emergencies\/zika-virus\/history\/en\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3389\/fmicb.2017.01554","article-title":"Zika virus: What have we learnt since the start of the recent epidemic?","volume":"8","author":"Saiz","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_7","unstructured":"(2019, June 20). Available online: http:\/\/www.who.int\/emergencies\/zika-virus\/history\/en\/."},{"key":"ref_8","unstructured":"(2019, June 20). Available online: http:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=11599&Itemid=41691&lang=en."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00705-006-0903-z","article-title":"Full-length sequencing and genomic characterization of bagaza, kedougou, and zika viruses","volume":"152","author":"Kuno","year":"2007","journal-title":"Arch. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on yap island, federated states of micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5501\/wjv.v5.i4.135","article-title":"Neurological manifestations of zika virus infection","volume":"5","author":"Blazquez","year":"2016","journal-title":"World J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41585-019-0149-7","article-title":"Persistence and clinical relevance of zika virus in the male genital tract","volume":"16","author":"Kurscheidt","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Martin-Acebes, M.A., and Saiz, J.C. (2019). The scientific response to zika virus. J. Clin. Med., 8.","DOI":"10.3390\/jcm8030369"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nazerai, L., Pravsgaard Christensen, J., and Randrup Thomsen, A. (2019). A \u2018furry-tale\u2019 of zika virus infection: What have we learned from animal models?. Viruses, 11.","DOI":"10.3390\/v11010029"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Alves, M.P., Vielle, N.J., Thiel, V., and Pfaender, S. (2018). Research models and tools for the identification of antivirals and therapeutics against zika virus infection. Viruses, 10.","DOI":"10.3390\/v10110593"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"McArthur, M.A. (2017). Zika virus: Recent advances towards the development of vaccines and therapeutics. Viruses, 9.","DOI":"10.3390\/v9060143"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41594-017-0010-8","article-title":"Structural biology of zika virus and other flaviviruses","volume":"25","author":"Hasan","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/M17-0641","article-title":"Evaluating vaccination strategies for zika virus in the americas","volume":"168","author":"Durham","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_19","unstructured":"(2019, June 20). Available online: https:\/\/www.who.int\/immunization\/research\/development\/WHO_UNICEF_Zikavac_TPP_Feb2017.pdf?ua=1."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"46375","DOI":"10.1038\/srep46375","article-title":"Protective efficacy of zika vaccine in ag129 mouse model","volume":"7","author":"Sumathy","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_21","unstructured":"(2019, June 20). Available online: http:\/\/ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=16798&EncHid=&userName=CTRI\/2017\/05\/008539."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated zika virus vaccine candidate: Phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2017","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against zika virus from brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In vivo protection against zikv infection and pathogenesis through passive antibody transfer and active immunisation with a prmenv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"NPJ Vaccines"},{"key":"ref_26","unstructured":"Tebas, P., Roberts, C.C., Muthumani, K., Reuschel, E.L., Kudchodkar, S.B., Zaidi, F.I., White, S., Khan, A.S., Racine, T., and Choi, H. (2017). Safety and immunogenicity of an anti-zika virus DNA vaccine\u2014Preliminary report. N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two zika virus DNA vaccine candidates in healthy adults: Randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mrna vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","article-title":"Vaccine mediated protection against zika virus-induced congenital disease","volume":"170","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nurnberger, C., Bodmer, B.S., Fiedler, A.H., Gabriel, G., and Muhlebach, M.D. (2019). A measles virus-based vaccine candidate mediates protection against zika virus in an allogeneic mouse pregnancy model. J. Virol., 93.","DOI":"10.1128\/JVI.01485-18"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16509","DOI":"10.1038\/s41598-018-34735-7","article-title":"Purified inactivated zika vaccine candidates afford protection against lethal challenge in mice","volume":"8","author":"Baldwin","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","article-title":"A single-dose live-attenuated vaccine prevents zika virus pregnancy transmission and testis damage","volume":"8","author":"Shan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.chom.2018.09.008","article-title":"A single-dose live-attenuated zika virus vaccine with controlled infection rounds that protects against vertical transmission","volume":"24","author":"Xie","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mrna vaccines protect against zika virus infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1016\/j.vaccine.2018.04.051","article-title":"Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal zika virus infection in immunocompetent balb\/c mice","volume":"36","author":"Wang","year":"2018","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2017.10.006","article-title":"A DNA vaccine protects human immune cells against zika virus infection in humanized mice","volume":"25","author":"Yi","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebiom.2018.08.056","article-title":"A single-dose plasmid-launched live-attenuated zika vaccine induces protective immunity","volume":"36","author":"Zou","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41598-017-00193-w","article-title":"An rna nanoparticle vaccine against zika virus elicits antibody and cd8+ t cell responses in a mouse model","volume":"7","author":"Chahal","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Boigard, H., Alimova, A., Martin, G.R., Katz, A., Gottlieb, P., and Galarza, J.M. (2017). Zika virus-like particle (vlp) based vaccine. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005608"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00834-17","DOI":"10.1128\/JVI.00834-17","article-title":"Development of virus-like-particle vaccine and reporter assay for zika virus","volume":"91","author":"Garg","year":"2017","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Salvo, M.A., Kingstad-Bakke, B., Salas-Quinchucua, C., Camacho, E., and Osorio, J.E. (2018). Zika virus like particles elicit protective antibodies in mice. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006210"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display zika virus envelope protein domain iii induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liang, H., Yang, R., Liu, Z., Li, M., Liu, H., and Jin, X. (2018). Recombinant zika virus envelope protein elicited protective immunity against zika virus in immunocompetent mice. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194860"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"To, A., Medina, L.O., Mfuh, K.O., Lieberman, M.M., Wong, T.A.S., Namekar, M., Nakano, E., Lai, C.Y., Kumar, M., and Nerurkar, V.R. (2018). Recombinant zika virus subunits are immunogenic and efficacious in mice. mSphere, 3.","DOI":"10.1128\/mSphere.00576-17"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3389\/fimmu.2018.02464","article-title":"A recombinant subunit based zika virus vaccine is efficacious in non-human primates","volume":"9","author":"Medina","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1038\/s41598-017-10595-5","article-title":"Immunization with truncated envelope protein of zika virus induces protective immune response in mice","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2018.04.010","article-title":"Insect cell-produced recombinant protein subunit vaccines protect against zika virus infection","volume":"154","author":"Qu","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-018-0572-7","article-title":"E90 subunit vaccine protects mice from zika virus infection and microcephaly","volume":"6","author":"Zhu","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of zika virus envelope protein domain iii induces specific and neutralizing immune responses against zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/pbi.12796","article-title":"Plant-produced zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against zika virus in mice","volume":"16","author":"Yang","year":"2017","journal-title":"Plant Biotechnol. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41426-017-0007-8","article-title":"Critical neutralizing fragment of zika virus ediii elicits cross-neutralization and protection against divergent zika viruses","volume":"7","author":"Tai","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e01722-17","DOI":"10.1128\/JVI.01722-17","article-title":"Recombinant chimpanzee adenovirus vaccine adc7-m\/e protects against zika virus infection and testis damage","volume":"92","author":"Xu","year":"2018","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/s41598-018-35755-z","article-title":"Efficacy of a t cell-biased adenovirus vector as a zika virus vaccine","volume":"8","author":"Bullard","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Cox, F., van der Fits, L., Abbink, P., Larocca, R.A., van Huizen, E., Saeland, E., Verhagen, J., Peterson, R., Tolboom, J., and Kaufmann, B. (2018). Adenoviral vector type 26 encoding zika virus (zikv) m-env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against zikv challenge. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202820"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/infdis\/jiy187","article-title":"Immunization with a novel human type 5 adenovirus-vectored vaccine expressing the premembrane and envelope proteins of zika virus provides consistent and sterilizing protection in multiple immunocompetent and immunocompromised animal models","volume":"218","author":"Guo","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17385","DOI":"10.1038\/s41598-018-35724-6","article-title":"A vaccine based on a modified vaccinia virus ankara vector expressing zika virus structural proteins controls zika virus replication in mice","volume":"8","author":"Perez","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.1038\/s41598-017-15039-8","article-title":"A zika vaccine targeting ns1 protein protects immunocompetent adult mice in a lethal challenge model","volume":"7","author":"Brault","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/s41467-018-03662-6","article-title":"A vaccinia-based single vector construct multi-pathogen vaccine protects against both zika and chikungunya viruses","volume":"9","author":"Prow","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1038\/s41598-018-29401-x","article-title":"A vsv-based zika virus vaccine protects mice from lethal challenge","volume":"8","author":"Emanuel","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41467-018-05276-4","article-title":"A zika virus vaccine expressing premembrane-envelope-ns1 polyprotein","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2018.05.095","article-title":"A recombinant virus vaccine that protects against both chikungunya and zika virus infections","volume":"36","author":"Chattopadhyay","year":"2018","journal-title":"Vaccine"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41467-018-02975-w","article-title":"Development of a chimeric zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13206","DOI":"10.1038\/s41598-018-31375-9","article-title":"Chimeric yellow fever 17d-zika virus (chimerivax-zika) as a live-attenuated zika virus vaccine","volume":"8","author":"Goncalvez","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41541-018-0092-2","article-title":"A yellow fever-zika chimeric virus vaccine candidate protects against zika infection and congenital malformations in mice","volume":"3","author":"Kum","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41426-018-0161-7","article-title":"Live zika virus chimeric vaccine candidate based on a yellow fever 17-d attenuated backbone","volume":"7","author":"Touret","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41591-018-0056-0","article-title":"Therapeutic and protective efficacy of a dengue antibody against zika infection in rhesus monkeys","volume":"24","author":"Abbink","year":"2018","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/cr.2016.144","article-title":"Transfer of convalescent serum to pregnant mice prevents zika virus infection and microcephaly in offspring","volume":"27","author":"Wang","year":"2017","journal-title":"Cell Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.celrep.2018.04.005","article-title":"A single injection of human neutralizing antibody protects against zika virus infection and microcephaly in developing mouse embryos","volume":"23","author":"Li","year":"2018","journal-title":"Cell Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Magnani, D.M., Rogers, T.F., Beutler, N., Ricciardi, M.J., Bailey, V.K., Gonzalez-Nieto, L., Briney, B., Sok, D., Le, K., and Strubel, A. (2017). Neutralizing human monoclonal antibodies prevent zika virus infection in macaques. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aan8184"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting zika virus ns1 provide protection against disease in a mouse model","volume":"9","author":"Bailey","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","article-title":"Zika virus vaccine development: Progress in the face of new challenges","volume":"70","author":"Diamond","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Saiz, J.C., and Martin-Acebes, M.A. (2017). The race to find antivirals for zika virus. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.00411-17"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.1016\/j.coviro.2014.08.002","article-title":"Editorial overview: Antivirals and resistance: Advances and challenges ahead","volume":"8","author":"Richman","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.antiviral.2017.06.001","article-title":"Zika in the americas, year 2: What have we learned? What gaps remain? A report from the global virus network","volume":"144","author":"Aliota","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2017.09.002","article-title":"A human bi-specific antibody against zika virus with high therapeutic potential","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1038\/ncomms15672","article-title":"A peptide-based viral inactivator inhibits zika virus infection in pregnant mice and fetuses","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1038\/s41598-018-27855-7","article-title":"Co-protoporphyrin ix and sn-protoporphyrin ix inactivate zika, chikungunya and other arboviruses by targeting the viral envelope","volume":"8","author":"Neris","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcis.2019.02.010","article-title":"Benzoxazine monomer derived carbon dots as a broad-spectrum agent to block viral infectivity","volume":"542","author":"Huang","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2019.01.005","article-title":"Anti-zika virus activity of polyoxometalates","volume":"163","author":"Francese","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acsinfecdis.8b00322","article-title":"Small molecules targeting the flavivirus e protein with broad-spectrum activity and antiviral efficacy in vivo","volume":"5","author":"Li","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/acs.jmedchem.9b00142","article-title":"Anti-zika activity of a library of synthetic carbohydrate receptors","volume":"62","author":"Palanichamy","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chembiol.2018.05.011","article-title":"Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein","volume":"25","author":"Lian","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/acsinfecdis.8b00127","article-title":"Discovery of immunologically inspired small molecules that target the viral envelope protein","volume":"4","author":"Lian","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.antiviral.2019.02.008","article-title":"Identification of small molecule inhibitors targeting the zika virus envelope protein","volume":"164","author":"Pitts","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Mazzon, M., Ortega-Prieto, A.M., Imrie, D., Luft, C., Hess, L., Czieso, S., Grove, J., Skelton, J.K., Farleigh, L., and Bugert, J.J. (2019). Identification of broad-spectrum antiviral compounds by targeting viral entry. Viruses, 11.","DOI":"10.3390\/v11020176"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00705-019-04172-6","article-title":"Expression, purification and virucidal activity of two recombinant isoforms of phospholipase a2 from crotalus durissus terrificus venom","volume":"164","author":"Russo","year":"2019","journal-title":"Arch. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Clain, E., Haddad, J.G., Koishi, A.C., Sinigaglia, L., Rachidi, W., Despres, P., Duarte Dos Santos, C.N., Guiraud, P., Jouvenet, N., and El Kalamouni, C. (2019). The polyphenol-rich extract from psiloxylon mauritianum, an endemic medicinal plant from reunion island, inhibits the early stages of dengue and zika virus infection. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081860"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1038\/s41598-018-29183-2","article-title":"Extract from aphloia theiformis, an edible indigenous plant from reunion island, impairs zika virus attachment to the host cell surface","volume":"8","author":"Clain","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2016.06.012","article-title":"The green tea molecule egcg inhibits zika virus entry","volume":"496","author":"Carneiro","year":"2016","journal-title":"Virology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijbiomac.2017.06.105","article-title":"Epigallocatechin gallate, an active green tea compound inhibits the zika virus entry into host cells via binding the envelope protein","volume":"104","author":"Sharma","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3389\/fmicb.2017.01314","article-title":"Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses west nile virus, zika virus, and dengue virus","volume":"8","author":"Saiz","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2019.04.003","article-title":"Antiviral activity of pinocembrin against zika virus replication","volume":"167","author":"Lee","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e00380-18","DOI":"10.1128\/AAC.00380-18","article-title":"Extinction of zika virus and usutu virus by lethal mutagenesis reveals different patterns of sensitivity to three mutagenic drugs","volume":"62","author":"Bassi","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3851\/IMP3180","article-title":"In vitro susceptibility of geographically and temporally distinct zika viruses to favipiravir and ribavirin","volume":"22","author":"Baz","year":"2017","journal-title":"Antivir. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.08.007","article-title":"Ribavirin inhibits zika virus (zikv) replication in vitro and suppresses viremia in zikv-infected stat1-deficient mice","volume":"146","author":"Kamiyama","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Kim, J.A., Seong, R.K., Kumar, M., and Shin, O.S. (2018). Favipiravir and ribavirin inhibit replication of asian and african strains of zika virus in different cell models. Viruses, 10.","DOI":"10.3390\/v10020072"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00705-017-3436-8","article-title":"Viral polymerase inhibitors t-705 and t-1105 are potential inhibitors of zika virus replication","volume":"162","author":"Cai","year":"2017","journal-title":"Arch. Virol."},{"key":"ref_102","first-page":"e01983-17","article-title":"Zika virus replication is substantially inhibited by novel favipiravir and interferon alpha combination regimens","volume":"62","author":"Tao","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2017.11.004","article-title":"Merimepodib, an impdh inhibitor, suppresses replication of zika virus and other emerging viral pathogens","volume":"149","author":"Tong","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of fda-approved drugs for inhibitors of zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of zika virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jviromet.2016.09.015","article-title":"A sensitive virus yield assay for evaluation of antivirals against zika virus","volume":"238","author":"Goebel","year":"2016","journal-title":"J. Virol. Methods"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against zika virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.11.018","article-title":"Evaluation of anti-zika virus activities of broad-spectrum antivirals and nih clinical collection compounds using a cell-based, high-throughput screen assay","volume":"138","author":"Adcock","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Beck, S., Zhu, Z., Oliveira, M.F., Smith, D.M., Rich, J.N., Bernatchez, J.A., and Siqueira-Neto, J.L. (2019). Mechanism of action of methotrexate against zika virus. Viruses, 11.","DOI":"10.3390\/v11040338"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e00389-19","DOI":"10.1128\/JVI.00389-19","article-title":"Atovaquone inhibits arbovirus replication through the depletion of intracellular nucleotides","volume":"93","author":"Grande","year":"2019","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijantimicag.2017.08.016","article-title":"The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6mmpr) effectively blocks zika virus replication","volume":"50","author":"Felix","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.11.020","article-title":"Adenosine triphosphate analogs can efficiently inhibit the zika virus rna-dependent rna polymerase","volume":"137","author":"Hercik","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zmurko, J., Marques, R.E., Schols, D., Verbeken, E., Kaptein, S.J., and Neyts, J. (2016). The viral polymerase inhibitor 7-deaza-2\u2019-c-methyladenosine is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004695"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"ofw175","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine analog nitd008 is a potent inhibitor of zika virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound bcx4430 against zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/AAC.00282-16","article-title":"Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 interferon-independent antiviral state","volume":"60","author":"Chung","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Bernatchez, J.A., Coste, M., Beck, S., Wells, G.A., Luna, L.A., Clark, A.E., Zhu, Z., Hecht, D., Rich, J.N., and Sohl, C.D. (2019). Activity of selected nucleoside analogue protides against zika virus in human neural stem cells. Viruses, 11.","DOI":"10.1101\/533497"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.12688\/f1000research.9648.1","article-title":"Zika antiviral chemotherapy: Identification of drugs and promising starting points for drug discovery from an fda-approved library","volume":"5","author":"Pascoalino","year":"2016","journal-title":"F1000Research"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41426-018-0191-1","article-title":"Novel ar-12 derivatives, p12-23 and p12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis","volume":"7","author":"Yang","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The fda-approved drug sofosbuvir inhibits zika virus infection","volume":"137","author":"Govero","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e02054-17","DOI":"10.1128\/JVI.02054-17","article-title":"Viperin restricts zika virus and tick-borne encephalitis virus replication by targeting ns3 for proteasomal degradation","volume":"92","author":"Panayiotou","year":"2018","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-018-0238-4","article-title":"A naturally occurring antiviral ribonucleotide encoded by the human genome","volume":"558","author":"Gizzi","year":"2018","journal-title":"Nature"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3389\/fmicb.2019.00718","article-title":"Potent inhibition of zika virus replication by aurintricarboxylic acid","volume":"10","author":"Park","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1021\/jacs.6b10399","article-title":"Structural insight into ns5 of zika virus leading to the discovery of mtase inhibitors","volume":"138","author":"Stephen","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbrc.2016.11.098","article-title":"Structure of the ns5 methyltransferase from zika virus and implications in inhibitor design","volume":"492","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e02202-16","DOI":"10.1128\/JVI.02202-16","article-title":"Zika virus methyltransferase: Structure and functions for drug design perspectives","volume":"91","author":"Coutard","year":"2017","journal-title":"J. Virol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","article-title":"Inhibitory effect of flavonoids against ns2b-ns3 protease of zika virus and their structure activity relationship","volume":"39","author":"Lim","year":"2016","journal-title":"Biotechnol. Lett."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Roy, A., Lim, L., Srivastava, S., Lu, Y., and Song, J. (2017). Solution conformations of zika ns2b-ns3pro and its inhibition by natural products from edible plants. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180632"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2018.10.019","article-title":"Zika virus ns2b\/ns3 proteinase: A new target for an old drug - suramin a lead compound for ns2b\/ns3 proteinase inhibition","volume":"160","author":"Coronado","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for zika virus by targeting ns2b-ns3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as zika virus ns2b-ns3 protease inhibitors that potently inhibit zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","article-title":"Novel antiviral activity and mechanism of bromocriptine as a zika virus ns2b-ns3 protease inhibitor","volume":"141","author":"Chan","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against ns2b\/ns3 serine protease from zika virus","volume":"139","author":"Lee","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"15771","DOI":"10.1038\/s41598-017-15467-6","article-title":"Repurposing of the anti-malaria drug chloroquine for zika virus treatment and prophylaxis","volume":"7","author":"Shiryaev","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural evidence for regulation and specificity of flaviviral proteases and evolution of the flaviviridae fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","article-title":"Ligand-bound structures of the dengue virus protease reveal the active conformation","volume":"86","author":"Noble","year":"2011","journal-title":"J. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Brecher, M., Li, Z., Liu, B., Zhang, J., Koetzner, C.A., Alifarag, A., Jones, S.A., Lin, Q., Kramer, L.D., and Li, H. (2017). A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus ns2b-ns3 protease. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006411"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin b is a potent and broad-spectrum orthosteric inhibitor of the flavivirus ns2b-ns3 protease","volume":"150","author":"Li","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"De Clercq, E., and Neyts, J. (2009). Antiviral agents acting as DNA or rna chain terminators. Handb. Exp. Pharmacol., 53\u201384.","DOI":"10.1007\/978-3-540-79086-0_3"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","article-title":"Ribavirin--current status of a broad spectrum antiviral agent","volume":"2","author":"Snell","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Lucas-Hourani, M., Dauzonne, D., Jorda, P., Cousin, G., Lupan, A., Helynck, O., Caignard, G., Janvier, G., Andre-Leroux, G., and Khiar, S. (2013). Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003678"},{"key":"ref_146","first-page":"10505","article-title":"Molecular mechanism of divalent-metal-induced activation of ns3 helicase and insights into zika virus inhibitor design","volume":"44","author":"Cao","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2016.12.018","article-title":"Extended substrate specificity and first potent irreversible inhibitor\/activity-based probe design for zika virus ns2b-ns3 protease","volume":"139","author":"Rut","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5808\/GI.2016.14.3.104","article-title":"Virtual screening for potential inhibitors of ns3 protein of zika virus","volume":"14","author":"Sahoo","year":"2016","journal-title":"Genom. Inform."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.drudis.2018.06.014","article-title":"The a-z of zika drug discovery","volume":"23","author":"Mottin","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chom.2009.04.001","article-title":"Pathogenesis of flavivirus infections: Using and abusing the host cell","volume":"5","author":"Mazzon","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: Dengue, zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Saiz, J.C., Oya, N.J., Blazquez, A.B., Escribano-Romero, E., and Martin-Acebes, M.A. (2018). Host-directed antivirals: A realistic alternative to fight zika virus. Viruses, 10.","DOI":"10.20944\/preprints201807.0359.v1"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.stem.2016.11.011","article-title":"Genetic ablation of axl does not protect human neural progenitor cells and cerebral organoids from zika virus infection","volume":"19","author":"Wells","year":"2016","journal-title":"Cell Stem. Cell"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.celrep.2016.12.045","article-title":"Axl mediates zika virus entry in human glial cells and modulates innate immune responses","volume":"18","author":"Meertens","year":"2017","journal-title":"Cell Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2017.03.014","article-title":"Curcumin inhibits zika and chikungunya virus infection by inhibiting cell binding","volume":"142","author":"Mounce","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e01018-18","DOI":"10.1128\/JVI.01018-18","article-title":"Nonsteroidal anti-inflammatory drugs potently inhibit the replication of zika viruses by inducing the degradation of axl","volume":"92","author":"Pan","year":"2018","journal-title":"J. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2018.02.003","article-title":"The molecular tweezer clr01 inhibits ebola and zika virus infection","volume":"152","author":"Rocker","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41563-018-0194-2","article-title":"Therapeutic treatment of zika virus infection using a brain-penetrating antiviral peptide","volume":"17","author":"Jackman","year":"2018","journal-title":"Nat. Mater."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Haviernik, J., Stefanik, M., Fojtikova, M., Kali, S., Tordo, N., Rudolf, I., Hubalek, Z., Eyer, L., and Ruzek, D. (2018). Arbidol (umifenovir): A broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses. Viruses, 10.","DOI":"10.20944\/preprints201802.0134.v1"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2019.03.004","article-title":"Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions","volume":"167","author":"Cannalire","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virol.2018.03.009","article-title":"Infection by zika viruses requires the transmembrane protein axl, endocytosis and low ph","volume":"518","author":"Persaud","year":"2018","journal-title":"Virology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e02227-16","DOI":"10.1128\/AAC.02227-16","article-title":"Obatoclax inhibits alphavirus membrane fusion by neutralizing the acidic environment of endocytic compartments","volume":"61","author":"Varghese","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jmv.25031","article-title":"The antimalarial drug amodiaquine possesses anti-zika virus activities","volume":"90","author":"Han","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1074\/jbc.RA118.005015","article-title":"A scorpion venom peptide ev37 restricts viral late entry by alkalizing acidic organelles","volume":"294","author":"Li","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","article-title":"Chloroquine, a fda-approved drug, prevents zika virus infection and its associated congenital microcephaly in mice","volume":"24","author":"Li","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Delvecchio, R., Higa, L.M., Pezzuto, P., Valadao, A.L., Garcez, P.P., Monteiro, F.L., Loiola, E.C., Dias, A.A., Silva, F.J., and Aliota, M.T. (2016). Chloroquine, an endocytosis blocking agent, inhibits zika virus infection in different cell models. Viruses, 8.","DOI":"10.1101\/051268"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1084\/jem.20170957","article-title":"Inhibition of autophagy limits vertical transmission of zika virus in pregnant mice","volume":"214","author":"Cao","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.11.015","article-title":"Antiviral activities of selected antimalarials against dengue virus type 2 and zika virus","volume":"137","author":"Balasubramanian","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e01206-18","DOI":"10.1128\/AAC.01206-18","article-title":"The small-compound inhibitor k22 displays broad antiviral activity against different members of the family flaviviridae and offers potential as a panviral inhibitor","volume":"62","author":"Vielle","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-018-0013-6","article-title":"Antiviral effects of ferric ammonium citrate","volume":"4","author":"Wang","year":"2018","journal-title":"Cell Discov."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Cairns, D.M., Boorgu, D., Levin, M., and Kaplan, D.L. (2018). Niclosamide rescues microcephaly in a humanized in vivo model of zika infection using human induced neural stem cells. Biol. Open, 7.","DOI":"10.1242\/bio.031807"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Elgner, F., Sabino, C., Basic, M., Ploen, D., Grunweller, A., and Hildt, E. (2018). Inhibition of zika virus replication by silvestrol. Viruses, 10.","DOI":"10.3390\/v10040149"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2017.10.014","article-title":"Antiviral activity of n-(4-hydroxyphenyl) retinamide (4-hpr) against zika virus","volume":"147","author":"Pitts","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Yang, S.N.Y., Atkinson, S.C., Fraser, J.E., Wang, C., Maher, B., Roman, N., Forwood, J.K., Wagstaff, K.M., Borg, N.A., and Jans, D.A. (2019). Novel flavivirus antiviral that targets the host nuclear transport importin alpha\/beta1 heterodimer. Cells, 8.","DOI":"10.3390\/cells8030281"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41182-017-0072-7","article-title":"Identification of novel antiviral of fungus-derived brefeldin a against dengue viruses","volume":"45","author":"Raekiansyah","year":"2017","journal-title":"Trop. Med. Health"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-018-0034-1","article-title":"Emetine inhibits zika and ebola virus infections through two molecular mechanisms: Inhibiting viral replication and decreasing viral entry","volume":"4","author":"Yang","year":"2018","journal-title":"Cell Discov."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1016\/j.celrep.2017.11.054","article-title":"A small-molecule oligosaccharyltransferase inhibitor with pan-flaviviral activity","volume":"21","author":"Puschnik","year":"2017","journal-title":"Cell Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature18625","article-title":"A crispr screen defines a signal peptide processing pathway required by flaviviruses","volume":"535","author":"Zhang","year":"2016","journal-title":"Nature"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.celrep.2017.03.071","article-title":"The natural product cavinafungin selectively interferes with zika and dengue virus replication by inhibition of the host signal peptidase","volume":"19","author":"Estoppey","year":"2017","journal-title":"Cell Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"ofx009","DOI":"10.1093\/ofid\/ofx009","article-title":"Pediatric drug nitazoxanide: A potential choice for control of zika","volume":"4","author":"Cao","year":"2017","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"34475","DOI":"10.1038\/srep34475","article-title":"Bithionol blocks pathogenicity of bacterial toxins, ricin, and zika virus","volume":"6","author":"Leonardi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Lin, S.C., Chen, M.C., Liu, S., Callahan, V.M., Bracci, N.R., Woodson, C.M., Dahal, B., de la Fuente, C.L., Lin, C.C., and Wang, T.T. (2019). Phloretin inhibits zika virus infection by interfering with the cellular glucose utilization. Int. J. Antimicrob. Agents.","DOI":"10.1016\/j.ijantimicag.2019.03.017"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e00376-17","DOI":"10.1128\/AAC.00376-17","article-title":"Antiviral activity of nordihydroguaiaretic acid and its derivative tetra-o-methyl nordihydroguaiaretic acid against west nile virus and zika virus","volume":"61","author":"Saiz","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/22221751.2019.1604084","article-title":"Targeting host metabolism by inhibition of acetyl-coenzyme a carboxylase reduces flavivirus infection in mouse models","volume":"8","author":"Esler","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e00360-18","DOI":"10.1128\/AAC.00360-18","article-title":"Direct activation of adenosine monophosphate-activated protein kinase (ampk) by pf-06409577 inhibits flavivirus infection through modification of host cell lipid metabolism","volume":"62","author":"Blazquez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e02019-17","DOI":"10.1128\/JVI.02019-17","article-title":"Suppression of zika virus infection and replication in endothelial cells and astrocytes by pka inhibitor pki 14-22","volume":"92","author":"Cheng","year":"2018","journal-title":"J. Virol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.immuni.2017.02.012","article-title":"25-hydroxycholesterol protects host against zika virus infection and its associated microcephaly in a mouse model","volume":"46","author":"Li","year":"2017","journal-title":"Immunity"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Tricarico, P.M., Caracciolo, I., Gratton, R., D\u2019Agaro, P., and Crovella, S. (2018). 25-hydroxycholesterol reduces inflammation, viral load and cell death in zikv-infected u-87 mg glial cell line. Inflammopharmacology.","DOI":"10.1007\/s10787-018-0517-6"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Willard, K.A., Elling, C.L., Stice, S.L., and Brindley, M.A. (2018). The oxysterol 7-ketocholesterol reduces zika virus titers in vero cells and human neurons. Viruses, 11.","DOI":"10.3390\/v11010020"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41598-017-03316-5","article-title":"Imipramine inhibits chikungunya virus replication in human skin fibroblasts through interference with intracellular cholesterol trafficking","volume":"7","author":"Wichit","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1038\/s41598-018-29329-2","article-title":"Determination of system level alterations in host transcriptome due to zika virus (zikv) infection in retinal pigment epithelium","volume":"8","author":"Singh","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-4159.2006.04309.x","article-title":"Lovastatin attenuates nerve injury in an animal model of guillain-barre syndrome","volume":"100","author":"Sarkey","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41421-018-0017-2","article-title":"Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor gw4869","volume":"4","author":"Huang","year":"2018","journal-title":"Cell Discov."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.stem.2017.06.017","article-title":"High-content screening in hpsc-neural progenitors identifies drug candidates that inhibit zika virus infection in fetal-like organoids and adult brain","volume":"21","author":"Zhou","year":"2017","journal-title":"Cell Stem. Cell"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.celrep.2018.12.095","article-title":"Zika virus dependence on host hsp70 provides a protective strategy against infection and disease","volume":"26","author":"Taguwa","year":"2019","journal-title":"Cell Rep."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2016.04.017","article-title":"Zika virus disrupts neural progenitor development and leads to microcephaly in mice","volume":"19","author":"Li","year":"2016","journal-title":"Cell Stem. Cell"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e00350-17","DOI":"10.1128\/mBio.00350-17","article-title":"N-methyl-d-aspartate (nmda) receptor blockade prevents neuronal death induced by zika virus infection","volume":"8","author":"Costa","year":"2017","journal-title":"MBio"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Simanjuntak, Y., Liang, J.J., Chen, S.Y., Li, J.K., Lee, Y.L., Wu, H.C., and Lin, Y.L. (2018). Ebselen alleviates testicular pathology in mice with zika virus infection and prevents its sexual transmission. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006854"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Lei, J., Vermillion, M.S., Jia, B., Xie, H., Xie, L., McLane, M.W., Sheffield, J.S., Pekosz, A., Brown, A., and Klein, S.L. (2019). Il-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following zika virus infection. JCI Insight., 4.","DOI":"10.1172\/jci.insight.122678"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2016.03.008","article-title":"Type iii interferons produced by human placental trophoblasts confer protection against zika virus infection","volume":"19","author":"Bayer","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Contreras, D., and Arumugaswami, V. (2016). Zika virus infectious cell culture system and the in vitro prophylactic effect of interferons. J. Vis. Exp.","DOI":"10.3791\/54767-v"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chom.2017.08.012","article-title":"Gestational stage and ifn-lambda signaling regulate zikv infection in utero","volume":"22","author":"Jagger","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","article-title":"The ifitms inhibit zika virus replication","volume":"15","author":"Savidis","year":"2016","journal-title":"Cell Rep."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e00452-17","DOI":"10.1128\/mBio.00452-17","article-title":"A novel agonist of the trif pathway induces a cellular state refractory to replication of zika, chikungunya, and dengue viruses","volume":"8","author":"Pryke","year":"2017","journal-title":"MBio"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12250-018-0068-4","article-title":"The scorpion venom peptide smp76 inhibits viral infection by regulating type-i interferon response","volume":"33","author":"Ji","year":"2018","journal-title":"Virol. Sin."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"e02388-16","DOI":"10.1128\/JVI.02388-16","article-title":"A microrna screen identifies the wnt signaling pathway as a regulator of the interferon response during flavivirus infection","volume":"91","author":"Smith","year":"2017","journal-title":"J. Virol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"e01141-17","DOI":"10.1128\/mBio.01141-17","article-title":"Inhibitors of the histone methyltransferases ezh2\/1 induce a potent antiviral state and suppress infection by diverse viral pathogens","volume":"8","author":"Arbuckle","year":"2017","journal-title":"MBio"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1099\/jgv.0.000886","article-title":"Axl is not an indispensable factor for zika virus infection in mice","volume":"98","author":"Wang","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.116.309866","article-title":"Axl-mediated productive infection of human endothelial cells by zika virus","volume":"119","author":"Liu","year":"2016","journal-title":"Circ. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virusres.2012.05.024","article-title":"Acid-dependent viral entry","volume":"167","author":"Saiz","year":"2012","journal-title":"Virus Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.plipres.2016.09.005","article-title":"Lipids and flaviviruses, present and future perspectives for the control of dengue, zika, and west nile viruses","volume":"64","author":"Saiz","year":"2016","journal-title":"Prog. Lipid. Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.chom.2016.06.011","article-title":"Interferon-induced spermidine-spermine acetyltransferase and polyamine depletion restrict zika and chikungunya viruses","volume":"20","author":"Mounce","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1128\/JVI.01347-16","article-title":"Inhibition of polyamine biosynthesis is a broad-spectrum strategy against rna viruses","volume":"90","author":"Mounce","year":"2016","journal-title":"J. Virol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika virus infects human cortical neural progenitors and attenuates their growth","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem. Cell"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Martin-Acebes, M.A., Jimenez de Oya, N., and Saiz, J.C. (2019). Lipid metabolism as a source of druggable targets for antiviral discovery against zika and other flaviviruses. Pharmaceuticals, 12.","DOI":"10.3390\/ph12020097"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature18296","article-title":"The brazilian zika virus strain causes birth defects in experimental models","volume":"534","author":"Cugola","year":"2016","journal-title":"Nature"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.aaf6116","article-title":"Zika virus impairs growth in human neurospheres and brain organoids","volume":"352","author":"Garcez","year":"2016","journal-title":"Science"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Lee, I., Bos, S., Li, G., Wang, S., Gadea, G., Despres, P., and Zhao, R.Y. (2018). Probing molecular insights into zika virus (-) host interactions. Viruses, 10.","DOI":"10.20944\/preprints201804.0063.v1"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/vim.2017.0046","article-title":"Zika virus: Immune evasion mechanisms, currently available therapeutic regimens, and vaccines","volume":"30","author":"Asif","year":"2017","journal-title":"Viral. Immunol."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Bowen, J.R., Quicke, K.M., Maddur, M.S., O\u2019Neal, J.T., McDonald, C.E., Fedorova, N.B., Puri, V., Shabman, R.S., Pulendran, B., and Suthar, M.S. (2017). Zika virus antagonizes type i interferon responses during infection of human dendritic cells. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006164"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41564-017-0092-4","article-title":"Axl promotes zika virus infection in astrocytes by antagonizing type i interferon signalling","volume":"3","author":"Chen","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika virus targets human stat2 to inhibit type i interferon signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embr.201642627","article-title":"Zika virus inhibits type-i interferon production and downstream signaling","volume":"17","author":"Kumar","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Yockey, L.J., Jurado, K.A., Arora, N., Millet, A., Rakib, T., Milano, K.M., Hastings, A.K., Fikrig, E., Kong, Y., and Horvath, T.L. (2018). Type i interferons instigate fetal demise after zika virus infection. Sci. Immunol., 3.","DOI":"10.1126\/sciimmunol.aao1680"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/12\/3\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:21Z","timestamp":1760188521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/12\/3\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":227,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["ph12030127"],"URL":"https:\/\/doi.org\/10.3390\/ph12030127","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]}}}